• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Meningococcemia and purpura fulminans in adults: acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates.

作者信息

Fourrier F, Lestavel P, Chopin C, Marey A, Goudemand J, Rime A, Mangalaboyi J

机构信息

Service de Réanimation Polyvalente, Hôpital B, Lille, France.

出版信息

Intensive Care Med. 1990;16(2):121-4. doi: 10.1007/BF02575306.

DOI:10.1007/BF02575306
PMID:2139671
Abstract

It has been recently suggested that an acquired deficiency of proteins C and S could contribute to the pathogenesis of meningococcemic purpura fulminans (PF) in children. Our study was designed to measure the levels of antithrombin III (AT III), protein C, and protein S during adult PF and to determine the effects of an early infusion of high doses of AT III concentrates on clinical and biological alterations of PF. We studied five consecutive adult patients with meningococcemia (type B) and PF. The levels of AT III, protein C (antigen and activity), and protein S (total and free) were measured at admission and 24 h and 1 month later. The treatment included in each case: amoxycillin, dobutamine and high doses of AT III concentrates. All patients survived and were discharged without any sequelae. At admission, biological data were consistent with severely depressed protein C and protein S levels and moderately decreased AT III levels, without any discrepancy between protein C antigen and activity. After 24 h, AT III and protein S levels were within normal ranges, whereas protein C levels were still depressed. These data are consistent with the theory of a particular imbalance in the anticoagulant systems during meningococcemic PF, contrasting with the usual findings observed during septic disseminated intravascular coagulation. The possibility must be considered that high doses of one anticoagulant (AT III concentrates) could compensate for the acute decrease in the other (protein C system).

摘要

相似文献

1
Meningococcemia and purpura fulminans in adults: acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates.
Intensive Care Med. 1990;16(2):121-4. doi: 10.1007/BF02575306.
2
Protein C and protein S levels in two patients with acquired purpura fulminans.两名获得性暴发性紫癜患者的蛋白C和蛋白S水平。
Br J Haematol. 1990 May;75(1):112-7. doi: 10.1111/j.1365-2141.1990.tb02625.x.
3
Purpura fulminans in meningococcemia: association with acquired deficiencies of proteins C and S.暴发性紫癜在脑膜炎球菌血症中的情况:与蛋白C和蛋白S后天缺乏的关联
N Engl J Med. 1987 Aug 27;317(9):571-2. doi: 10.1056/NEJM198708273170912.
4
Rapid recovery of acquired purpura fulminans in a patient with familial C4bBP deficiency.一名患有家族性C4bBP缺乏症的患者获得性暴发性紫癜的快速康复。
Intensive Care Med. 1993;19(2):115-6. doi: 10.1007/BF01708373.
5
Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans.蛋白C浓缩物对患有脑膜炎球菌败血症和暴发性紫癜的婴幼儿及青少年进行替代治疗。
Semin Thromb Hemost. 1999;25(6):537-41. doi: 10.1055/s-2007-994962.
6
An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia.一项关于蛋白C替代疗法辅助止血支持在暴发性紫癜相关脑膜炎球菌血症中作用的开放标签研究。
Blood. 2000 Dec 1;96(12):3719-24.
7
Epidemic meningococcemia and purpura fulminans with induced protein C deficiency.流行性脑膜炎球菌血症与暴发性紫癜伴诱导性蛋白C缺乏症。
Clin Infect Dis. 1993 Aug;17(2):254-61. doi: 10.1093/clinids/17.2.254.
8
Protein C and S deficiency in severe infectious purpura of children: a collaborative study of 40 cases.
Intensive Care Med. 1992;18(4):202-5. doi: 10.1007/BF01709832.
9
Treatment of purpura fulminans in meningococcemia with protein C concentrate.用蛋白C浓缩物治疗暴发性紫癜型脑膜炎球菌血症。
J Pediatr. 1995 Apr;126(4):646-52. doi: 10.1016/s0022-3476(95)70369-1.
10
[Purpura fulminans in the newborn. Report of two cases successfully treated with heparin and antithrombin III].[新生儿暴发性紫癜。两例经肝素和抗凝血酶III成功治疗的报告]
Minerva Pediatr. 1997 Dec;49(12):571-7.

引用本文的文献

1
Encephalomalacia/gliosis, deep venous thrombosis, and cancer in Arg393His antithrombin Hanoi and the potential impact of the β-amyloid precursor protein (APP) on thrombosis and cancer.在携带393位精氨酸突变为组氨酸的抗凝血酶的河内患者中出现的脑软化/胶质增生、深静脉血栓形成和癌症,以及β-淀粉样前体蛋白(APP)对血栓形成和癌症的潜在影响。
AIMS Neurosci. 2022 Apr 21;9(2):175-215. doi: 10.3934/Neuroscience.2022010. eCollection 2022.
2
Four-extremity amputation following disseminated intravascular coagulation and purpura fulminans.弥散性血管内凝血和暴发性紫癜后四肢截肢
BMJ Case Rep. 2019 Mar 20;12(3):e228028. doi: 10.1136/bcr-2018-228028.
3
Identification of differentially expressed serum proteins in infectious purpura fulminans.
鉴定暴发性传染性紫癜中差异表达的血清蛋白。
Dis Markers. 2014;2014:698383. doi: 10.1155/2014/698383. Epub 2014 Feb 10.
4
Protein C promoter polymorphisms associate with sepsis in children with systemic meningococcemia.蛋白C启动子多态性与全身性脑膜炎球菌血症患儿的败血症相关。
Hum Genet. 2007 Sep;122(2):183-90. doi: 10.1007/s00439-007-0392-5. Epub 2007 Jun 14.
5
4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia.全身性脑膜炎球菌血症患儿纤溶酶原激活物抑制剂-1基因中的4G/5G启动子多态性
Eur J Pediatr. 2005 Aug;164(8):486-90. doi: 10.1007/s00431-005-1673-4. Epub 2005 Apr 21.
6
Pathophysiology of meningococcal meningitis and septicaemia.脑膜炎球菌性脑膜炎和败血症的病理生理学
Arch Dis Child. 2003 Jul;88(7):601-7. doi: 10.1136/adc.88.7.601.
7
Combined antithrombin and protein C supplementation in meningococcal purpura fulminans: a pharmacokinetic study.
Intensive Care Med. 2003 Jul;29(7):1081-7. doi: 10.1007/s00134-003-1784-1. Epub 2003 May 22.
8
Emerging therapies in severe sepsis.重症脓毒症的新兴疗法
Thorax. 2002 Oct;57 Suppl 2(Suppl 2):II8-II14.
9
Recognition, treatment and complications of meningococcal disease.脑膜炎球菌病的识别、治疗及并发症
Paediatr Drugs. 1999 Oct-Dec;1(4):263-82. doi: 10.2165/00128072-199901040-00003.
10
Update on meningococcal disease with emphasis on pathogenesis and clinical management.脑膜炎球菌病最新进展,重点关注发病机制与临床管理。
Clin Microbiol Rev. 2000 Jan;13(1):144-66, table of contents. doi: 10.1128/CMR.13.1.144.